Consensus Medtronic plc

Equities

MDT

IE00BTN1Y115

Market Closed - Nyse Other stock markets 01:30:02 10/09/2024 am IST			5-day change	1st Jan Change
90.62 ^USD	+0.81%		+2.30%	+10.00%

04/09	Transcript : Medtronic plc Presents at Wells Fargo 2024 Healthcare Conference, Sep-04-2024 11:55 AM
27/08	Tranche Update on Medtronic plc's Equity Buyback Plan announced on June 23, 2017.	CI

Evolution of the Average Target: Medtronic plc

Evolution of the Target Price: Medtronic plc

Changes in Analyst Recommendations: Medtronic plc

566ed297d6ba63cc74ba1a9e.V91CZ1U5NnS93jsPGcj_lsIxhBu7wRm4nWQL4KBFCWI.IJM6ET10bhLE82I-TIarofFI7kiOsU-IyRxUmtJzfhYiuzELEGFaWdKPVA~569ef3e8d69795670ae33dcc7f8cc9cd

Analysts' recommendations: Medtronic plc

Daiwa Securities Adjusts Price Target on Medtronic to $99 From $92, Maintains Buy Rating	23/08	MT
Truist Adjusts Medtronic's PT to $90 From $85, Keeps Hold Rating	22/08	MT
ARC Independent Raises Medtronic's Price Target to $97 From $96	21/08	MT
Oppenheimer Adjusts Medtronic Price Target to $94 From $92, Maintains Perform Rating	21/08	MT
Mizuho Adjusts Price Target on Medtronic to $98 From $95, Maintains Outperform	21/08	MT
Piper Sandler Adjusts Price Target on Medtronic to $90 From $85, Maintains Neutral	21/08	MT
Goldman Sachs Adjusts Price Target on Medtronic to $82 From $77, Maintains Sell Rating	21/08	MT
Stifel Adjusts Price Target on Medtronic to $87 From $85, Maintains Hold Rating	21/08	MT
Baird Adjusts Price Target on Medtronic to $90 From $82, Maintains Neutral Rating	21/08	MT
Wells Fargo Adjusts Price Target on Medtronic to $106 From $105, Maintains Overweight	21/08	MT
UBS Upgrades Medtronic to Neutral From Sell, Raises Price Target to $90 From $76	15/08	MT
UBS Upgrades Medtronic to Neutral From Sell	15/08	MT
Stifel Downgrades Medtronic to Hold From Buy, Adjusts Price Target to $85 From $100	14/08	MT
Analyst recommendations: Intuit, Medtronic, Pultegroup, Qualcomm, Starbucks...	14/08
Baird Cuts Price Target on Medtronic to $82 From $87, Maintains Neutral Rating	16/07	MT
Truist Trims Price Target on Medtronic to $85 From $88, Keeps Hold Rating	16/07	MT
Mizuho Securities Cuts Price Target on Medtronic to $95 From $98	12/07	MT
Goldman Sachs Adjusts Price Target on Medtronic to $77 From $83	10/07	MT
Citigroup Adjusts Price Target on Medtronic to $85 From $90	10/07	MT
Daiwa Securities Adjusts Price Target on Medtronic to $92 From $100	30/05	MT
UBS Adjusts Medtronic Price Target to $76 From $75, Maintains Sell Rating	24/05	MT
Bernstein Adjusts Price Target on Medtronic to $96 From $97	24/05	MT
Truist Securities Adjusts Price Target on Medtronic to $88 From $90, Keeps Hold Rating	24/05	MT
Wolfe Research Adjusts Price Target on Medtronic to $82 From $80	24/05	MT
Baird Adjusts Price Target on Medtronic to $87 From $88	24/05	MT

More recommendations

Sector Comparison:

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analyst Opinion	4m Revision of opinion	Divergence of analysts' opinions	Divergence of Target Price	Ecart obj. / dr
	MEDTRONIC PLC					+5.26%
	ABBOTT LABORATORIES					+9.15%
	BECTON, DICKINSON AND COMPANY					+19.27%
	HOYA CORPORATION					+15.32%
	CENCORA, INC.					+11.42%
	METTLER-TOLEDO INTERNATIONAL, INC.					+0.53%
	TERUMO CORPORATION					+21.52%
	DEXCOM, INC.					+39.73%
	STERIS PLC					+2.97%
	WEST PHARMACEUTICAL SERVICES, INC.					+18.37%
	Average					+14.35%
	Weighted average by Cap.					+11.82%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

90.62USD

Average target price

94.62USD

Spread / Average Target

+4.41%

High Price Target

112.00USD

Spread / Highest target

+23.59%

Low Price Target

82.00USD

Spread / Lowest Target

-9.51%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Daiwa Securities
UBS
Bernstein
Truist Securities
Wolfe Research
Baird
Wells Fargo Securities
Piper Sandler
Deutsche Bank Securities
Mizuho Securities
Oppenheimer
RBC Capital Markets
Morgan Stanley
Stifel Nicolaus
CL King
Evercore ISI
Barclays
Citigroup
Jefferies & Co.
Goldman Sachs
Raymond James
Atlantic Equities
Cowen
JPMorgan Chase
Needham & Co.
Guggenheim
BofA Securities
Credit Suisse
SVB Leerink
BTIG
Argus